These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 34867951)
1. Circulating Exosome Involves in the Pathogenesis of Autoimmune Thyroid Diseases Through Immunomodulatory Proteins. Jia X; Zhai T; Zhang JA Front Immunol; 2021; 12():730089. PubMed ID: 34867951 [TBL] [Abstract][Full Text] [Related]
2. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis. Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030 [TBL] [Abstract][Full Text] [Related]
3. Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis. Song RH; Yu ZY; Qin Q; Wang X; Muhali FS; Shi LF; Jiang WJ; Xiao L; Li DF; Zhang JA Int J Clin Exp Pathol; 2014; 7(7):4024-31. PubMed ID: 25120780 [TBL] [Abstract][Full Text] [Related]
4. The MAGI2 gene polymorphism rs2160322 is associated with Graves' disease but not with Hashimoto's thyroiditis. Jia X; Zhai T; Wang B; Zhang J; Zhang F J Endocrinol Invest; 2019 Jul; 42(7):843-850. PubMed ID: 30535759 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of CLEC16A region and autoimmune thyroid diseases. Muhali FS; Cai TT; Zhu JL; Qin Q; Xu J; He ST; Shi XH; Jiang WJ; Xiao L; Li DF; Zhang JA G3 (Bethesda); 2014 Mar; 4(6):973-7. PubMed ID: 24646814 [TBL] [Abstract][Full Text] [Related]
6. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient. Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of CD4+CD161+CD196+ and CD4+IL-17+ Th17 cells in the peripheral blood of young patients with Hashimoto's thyroiditis and Graves' disease]. Bossowski A; Moniuszko M; Idźkowska E; Dąbrowska M; Jeznach M; Sawicka B; Borysewicz-Sańczyk H; Bossowska A; Rusak M; Bodzenta-Łukaszyk A Pediatr Endocrinol Diabetes Metab; 2012; 18(3):89-95. PubMed ID: 23146786 [TBL] [Abstract][Full Text] [Related]
8. HLA-A2 phenotype may be protective against Graves' disease but not against Hashimoto's thyroiditis in Caucasians. Bernecker C; Ostapczuk M; Vordenbäumen S; Ehlers M; Thiel A; Schinner S; Willenberg H; Scherbaum WA; Schott M Horm Metab Res; 2013 Jan; 45(1):74-7. PubMed ID: 22972181 [TBL] [Abstract][Full Text] [Related]
9. Changes of IgG Trzos S; Link-Lenczowski P; Sokołowski G; Pocheć E Front Immunol; 2022; 13():841710. PubMed ID: 35370997 [TBL] [Abstract][Full Text] [Related]
10. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response. Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response. Hiratsuka I; Itoh M; Yamada H; Yamamoto K; Tomatsu E; Makino M; Hashimoto S; Suzuki A Endocr J; 2015; 62(12):1059-66. PubMed ID: 26400025 [TBL] [Abstract][Full Text] [Related]
12. Tissue Infiltrating LTi-Like Group 3 Innate Lymphoid Cells and T Follicular Helper Cells in Graves' and Hashimoto's Thyroiditis. Mohr A; Trésallet C; Monot N; Bauvois A; Abiven D; Atif M; Claër L; Malhotra R; Mayer G; Balderas R; Vaarala O; Deniziaut G; Brocheriou I; Buffet C; Leenhardt L; Gorochov G; Miyara M Front Immunol; 2020; 11():601. PubMed ID: 32328068 [No Abstract] [Full Text] [Related]
13. Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves' disease. Wang X; Huang J; Zhang A; Fang C; Ma Q; Jiang P BMC Endocr Disord; 2021 Apr; 21(1):88. PubMed ID: 33926416 [TBL] [Abstract][Full Text] [Related]
14. Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases. Magnusson L; Espes D; Casas R; Carlsson PO Front Immunol; 2020; 11():1916. PubMed ID: 32983115 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of IKZF3 Gene and Autoimmune Thyroid Diseases: Associated with Graves' Disease but Not with Hashimoto's Thyroiditis. Li L; Ding X; Wang X; Yao Q; Shao X; An X; Yan N; Jiang Y; Wang W; Shi L; Qin Q; Song R; Zhang JA; Sun P Cell Physiol Biochem; 2018; 45(5):1787-1796. PubMed ID: 29510406 [TBL] [Abstract][Full Text] [Related]
16. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases. Molnár I; Bokk A Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110 [TBL] [Abstract][Full Text] [Related]
17. Expression Profile of Human Fc Receptor-Like 1, 2, and 4 Molecules in Peripheral Blood Mononuclear Cells of Patients with Hashimoto's Thyroiditis and Graves' Disease. Rostamzadeh D; Dabbaghmanesh MH; Shabani M; Hosseini A; Amirghofran Z Horm Metab Res; 2015 Aug; 47(9):693-8. PubMed ID: 25738996 [TBL] [Abstract][Full Text] [Related]
18. The Frequency of Intrathyroidal Follicular Helper T Cells Varies with the Progression of Graves' Disease and Hashimoto's Thyroiditis. Cai Y; Wang Z; Liu X; Wei L; Li S; Zheng X; Yang T; Xu X J Immunol Res; 2022; 2022():4075522. PubMed ID: 35224111 [TBL] [Abstract][Full Text] [Related]
19. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients. Wiebolt J; Achterbergh R; den Boer A; van der Leij S; Marsch E; Suelmann B; de Vries R; van Haeften TW Eur J Endocrinol; 2011 May; 164(5):789-94. PubMed ID: 21378091 [TBL] [Abstract][Full Text] [Related]
20. Research progress on the role and mechanism of action of exosomes in autoimmune thyroid disease. Chen Y; Dong B; Huang L; Zhou J; Huang H Int Rev Immunol; 2023; 42(5):334-346. PubMed ID: 35353670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]